Skip to main content
SpringerLink
Log in

Future Therapies for Retinitis Pigmentosa

  • Chapter
  • First Online:
Inherited Chorioretinal Dystrophies

  • 1669 Accesses

Abstract

Currently, there is no known effective treatment that can reverse the vision loss in retinitis pigmentosa (RP). To maintain and/or improve quality of life, patients would benefit from some supportive and preventive measures, such as vision aids, well-balanced diet, protection against stressful light, avoiding smoking and alcohol consumption, etc. Standard, evidence-based treatment modalities yet remain to be established.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McDonald H, Schatz H, Johnson R. Ocular phototoxicity. Curr Opin Ophthalmol. 1990;1:280–4.

    Article  Google Scholar 

  2. Schwartz L, Boelle PY, D’Hermies F, Ledanois G, Virmont J. Blue light dose distribution and retinitis pigmentosa visual field defects: an hypothesis. Med Hypotheses. 2003;60:644–9.

    Article  CAS  PubMed  Google Scholar 

  3. Park WL, Sunness JS. Red contact lenses for alleviation of photophobia in patients with cone disorders. Am J Ophthalmol. 2004;137:774–5.

    Article  PubMed  Google Scholar 

  4. Miyake Y, Sugita S, Horiguchi M, Yagasaki K. Light deprivation and retinitis pigmentosa. Am J Ophthalmol. 1990;110:305–6.

    Article  CAS  PubMed  Google Scholar 

  5. Berson EL. Light deprivation and retinitis pigmentosa. Vision Res. 1980;20:1179–84.

    Article  CAS  PubMed  Google Scholar 

  6. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: a review of association. Eye (Lond). 2005;19:935–44.

    Article  CAS  Google Scholar 

  7. Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, Buggage R, Pleil A, Mitchell P. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 2010;10:31.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Will JC, Galuska DA, Ford ES, Mokdad A, Calle EE. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int J Epidemiol. 2001;30:540–6.

    Article  CAS  PubMed  Google Scholar 

  9. Muhlhauser I, Bender R, Bott U, Jorgens V, Grusser M, Wagener W, Overmann H, Berger M. Cigarette smoking and progression of retinopathy and nephropathy in type 1 diabetes. Diabet Med. 1996;13:536–43.

    Article  CAS  PubMed  Google Scholar 

  10. Shimozono M, Townsend JC, Ilsen PF, Bright DC. Acute vision loss resulting from complications of ethanol abuse. J Am Optom Assoc. 1998;69:293–303.

    CAS  PubMed  Google Scholar 

  11. Stromland K. Ocular involvement in the fetal alcohol syndrome. Surv Ophthalmol. 1987;31:277–84.

    Article  CAS  PubMed  Google Scholar 

  12. Stromland K, Pinazo-Duran MD. Optic nerve hypoplasia: comparative effects in children and rats exposed to alcohol during pregnancy. Teratology. 1994;50:100–11.

    Article  CAS  PubMed  Google Scholar 

  13. Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco C, Willett W. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol. 1993;111:761–72.

    Article  CAS  PubMed  Google Scholar 

  14. Michaelsson K, Lithell H, Vessby B, Melhus H. Serum retinol levels and the risk of fracture. N Engl J Med. 2003;348:287–94.

    Article  CAS  PubMed  Google Scholar 

  15. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334:1150–5.

    Article  CAS  PubMed  Google Scholar 

  16. Hoffman DR, Locke KG, Wheaton DH, Fish GE, Spencer R, Birch DG. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. Am J Ophthalmol. 2004;137:704–18.

    CAS  PubMed  Google Scholar 

  17. Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Moser A, Brockhurst RJ, Hayes KC, Johnson CA, Anderson EJ, Gaudio AR, Willett WC, Schaefer EJ. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophthalmol. 2004;122:1306–14.

    Article  CAS  PubMed  Google Scholar 

  18. Aleman TS, Duncan JL, Bieber ML, de Castro E, Marks DA, Gardner LM, Steinberg JD, Cideciyan AV, Maguire MG, Jacobson SG. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Invest Ophthalmol Vis Sci. 2001;42:1873–81.

    CAS  PubMed  Google Scholar 

  19. Bahrami H, Melia M, Dagnelie G. Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289]. BMC Ophthalmol. 2006;6:23.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  20. Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Brockhurst RJ, Hayes KC, Johnson EJ, Anderson EJ, Johnson CA, Gaudio AR, Willett WC, Schaefer EJ. Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol. 2010;128:403–11.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Frasson M, Sahel JA, Fabre M, Simonutti M, Dreyfus H, Picaud S. Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse. Nat Med. 1999;5:1183–7.

    Article  CAS  PubMed  Google Scholar 

  22. Sato M, Ohguro H, Ohguro I, Mamiya K, Takano Y, Yamazaki H, Metoki T, Miyagawa Y, Ishikawa F, Nakazawa M. Study of pharmacological effects of nilvadipine on RCS rat retinal degeneration by microarray analysis. Biochem Biophys Res Commun. 2003;306:826–31.

    Article  CAS  PubMed  Google Scholar 

  23. Takano Y, Ohguro H, Dezawa M, Ishikawa H, Yamazaki H, Ohguro I, Mamiya K, Metoki T, Ishikawa F, Nakazawa M. Study of drug effects of calcium channel blockers on retinal degeneration of rd mouse. Biochem Biophys Res Commun. 2004;313:1015–22.

    Article  CAS  PubMed  Google Scholar 

  24. Nakazawa M, Ohguro H, Takeuchi K, Miyagawa Y, Ito T, Metoki T. Effect of nilvadipine on central visual field in retinitis pigmentosa: a 30-month clinical trial. Ophthalmologica. 2011;225:120–6.

    Article  CAS  PubMed  Google Scholar 

  25. Clemson CM, Tzekov R, Krebs M, Checchi JM, Bigelow C, Kaushal S. Therapeutic potential of valproic acid for retinitis pigmentosa. Br J Ophthalmol. 2011;95:89–93.

    Article  CAS  PubMed  Google Scholar 

  26. Fishman GA, Gilbert LD, Fiscella RG, Kimura AE, Jampol LM. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol. 1989;107:1445–52.

    Article  CAS  PubMed  Google Scholar 

  27. Grover S, Fishman GA, Fiscella RG, Adelman AE. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. Retina. 1997;17:222–31.

    Article  CAS  PubMed  Google Scholar 

  28. Artunay O, Yuzbasioglu E, Rasier R, Sengul A, Bahcecioglu H. Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa. J Ocul Pharmacol Ther. 2009;25:545–50.

    Article  CAS  PubMed  Google Scholar 

  29. Sahel J, Bonnel S, Mrejen S, Paques M. Retinitis pigmentosa and other dystrophies. Dev Ophthalmol. 2010;47:160–7.

    Article  PubMed  Google Scholar 

  30. Fahim AT, Daiger SP, Weleber RG. Retinitis pigmentosa overview. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, editors. GeneReviews™ [Internet]. Seattle: University of Washington; 1993. 2000 Aug 04 (updated 21 Mar 2013).

    Google Scholar 

  31. Bennett J, Tanabe T, Sun D, Zeng Y, Kjeldbye H, Gouras P, Maguire AM. Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy. Nat Med. 1996;2:649–54.

    Article  CAS  PubMed  Google Scholar 

  32. Ali RR, Sarra GM, Stephens C, Alwis MD, Bainbridge JW, Munro PM, Fauser S, Reichel MB, Kinnon C, Hunt DM, Bhattacharya SS, Thrasher AJ. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet. 2000;25:306–10.

    Article  CAS  PubMed  Google Scholar 

  33. Tschernutter M, Schlichtenbrede FC, Howe S, Balaggan KS, Munro PM, Bainbridge JW, Thrasher AJ, Smith AJ, Ali RR. Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy. Gene Ther. 2005;12:694–701.

    Article  CAS  PubMed  Google Scholar 

  34. Dejneka NS, Surace EM, Aleman TS, Cideciyan AV, Lyubarsky A, Savchenko A, Redmond TM, Tang W, Wei Z, Rex TS, Glover E, Maguire AM, Pugh Jr EN, Jacobson SG, Bennett J. In utero gene therapy rescues vision in a murine model of congenital blindness. Mol Ther. 2004;9:182–8.

    Article  CAS  PubMed  Google Scholar 

  35. Narfstrom K, Katz ML, Bragadottir R, Seeliger M, Boulanger A, Redmond TM, Caro L, Lai CM, Rakoczy PE. Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog. Invest Ophthalmol Vis Sci. 2003;44:1663–72.

    Article  PubMed  Google Scholar 

  36. Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, Cideciyan AV, Pearce-Kelling SE, Anand V, Zeng Y, Maguire AM, Jacobson SG, Hauswirth WW, Bennett J. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet. 2001;28:92–5.

    CAS  PubMed  Google Scholar 

  37. Acland GM, Aguirre GD, Bennett J, Aleman TS, Cideciyan AV, Bennicelli J, Dejneka NS, Pearce-Kelling SE, Maguire AM, Palczewski K, Hauswirth WW, Jacobson SG. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther. 2005;12:1072–82.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  38. Maguire AM, Simonelli F, Pierce EA, Pugh Jr EN, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, Rossi S, Lyubarsky A, Arruda VR, Konkle B, Stone E, Sun J, Jacobs J, Dell’Osso L, Hertle R, Ma JX, Redmond TM, Zhu X, Hauck B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe NJ, McDonnell JW, Auricchio A, High KA, Bennett J. Safety and efficacy of gene transfer for Leber’s congenital amaurosis. N Engl J Med. 2008;358:2240–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, Viswanathan A, Holder GE, Stockman A, Tyler N, Petersen-Jones S, Bhattacharya SS, Thrasher AJ, Fitzke FW, Carter BJ, Rubin GS, Moore AT, Ali RR. Effect of gene therapy on visual function in Leber’s congenital amaurosis. N Engl J Med. 2008;358:2231–9.

    Article  CAS  PubMed  Google Scholar 

  40. Jacobson SG, Cideciyan AV, Ratnakaram R, Heon E, Schwartz SB, Roman AJ, Peden MC, Aleman TS, Boye SL, Sumaroka A, Conlon TJ, Calcedo R, Pang JJ, Erger KE, Olivares MB, Mullins CL, Swider M, Kaushal S, Feuer WJ, Iannaccone A, Fishman GA, Stone EM, Byrne BJ, Hauswirth WW. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol. 2012;130:9–24.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  41. Cideciyan AV, Jacobson SG, Beltran WA, Sumaroka A, Swider M, Iwabe S, Roman AJ, Olivares MB, Schwartz SB, Komaromy AM, Hauswirth WW, Aguirre GD. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Proc Natl Acad Sci U S A. 2013;110:E517–25.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Testa F, Maguire AM, Rossi S, Pierce EA, Melillo P, Marshall K, Banfi S, Surace EM, Sun J, Acerra C, Wright JF, Wellman J, High KA, Auricchio A, Bennett J, Simonelli F. Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital amaurosis type 2. Ophthalmology. 2013;120(6):1283–91.

    Article  PubMed Central  PubMed  Google Scholar 

  43. Bennett J, Ashtari M, Wellman J, Marshall KA, Cyckowski LL, Chung DC, McCague S, Pierce EA, Chen Y, Bennicelli JL, Zhu X, Ying GS, Sun J, Wright JF, Auricchio A, Simonelli F, Shindler KS, Mingozzi F, High KA, Maguire AM. AAV2 gene therapy readministration in three adults with congenital blindness. Sci Transl Med. 2012;4(120):120ra15.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  44. Kong J, Kim SR, Binley K, Pata I, Doi K, Mannik J, Zernant-Rajang J, Kan O, Iqball S, Naylor S, Sparrow JR, Gouras P, Allikmets R. Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy. Gene Ther. 2008;15:1311–20.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Allocca M, Doria M, Petrillo M, Colella P, Garcia-Hoyos M, Gibbs D, Kim SR, Maguire A, Rex TS, Di Vicino U, Cutillo L, Sparrow JR, Williams DS, Bennett J, Auricchio A. Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. J Clin Invest. 2008;118:1955–64.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  46. Hashimoto T, Gibbs D, Lillo C, Azarian SM, Legacki E, Zhang XM, Yang XJ, Williams DS. Lentiviral gene replacement therapy of retinas in a mouse model for Usher syndrome type 1B. Gene Ther. 2007;14:584–94.

    Article  CAS  PubMed  Google Scholar 

  47. O’Neill B, Millington-Ward S, O’Reilly M, Tuohy G, Kiang AS, Kenna PF, Humphries P, Farrar GJ. Ribozyme-based therapeutic approaches for autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2000;41:2863–9.

    PubMed  Google Scholar 

  48. Cashman SM, Binkley EA, Kumar-Singh R. Towards mutation-independent silencing of genes involved in retinal degeneration by RNA interference. Gene Ther. 2005;12:1223–8.

    Article  CAS  PubMed  Google Scholar 

  49. Chadderton N, Millington-Ward S, Palfi A, O’Reilly M, Tuohy G, Humphries MM, Li T, Humphries P, Kenna PF, Farrar GJ. Improved retinal function in a mouse model of dominant retinitis pigmentosa following AAV-delivered gene therapy. Mol Ther. 2009;17:593–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  50. Millington-Ward S, Chadderton N, O’Reilly M, Palfi A, Goldmann T, Kilty C, Humphries M, Wolfrum U, Bennett J, Humphries P, Kenna PF, Farrar GJ. Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa. Mol Ther. 2011;19:642–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  51. Mao H, Gorbatyuk MS, Rossmiller B, Hauswirth WW, Lewin AS. Long-term rescue of retinal structure and function by rhodopsin RNA replacement with a single adeno-associated viral vector in P23H RHO transgenic mice. Hum Gene Ther. 2012;23:356–66.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  52. Wenzel A, Grimm C, Samardzija M, Reme CE. Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res. 2005;24:275–306.

    Article  CAS  PubMed  Google Scholar 

  53. Lau D, McGee LH, Zhou S, Rendahl KG, Manning WC, Escobedo JA, Flannery JG. Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2. Invest Ophthalmol Vis Sci. 2000;41:3622–33.

    CAS  PubMed  Google Scholar 

  54. Liang FQ, Aleman TS, Dejneka NS, Dudus L, Fisher KJ, Maguire AM, Jacobson SG, Bennett J. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa. Mol Ther. 2001;4:461–72.

    Article  CAS  PubMed  Google Scholar 

  55. Sieving PA, Caruso RC, Tao W, Coleman HR, Thompson DJ, Fullmer KR, Bush RA. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci U S A. 2006;103:3896–901.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  56. Talcott KE, Ratnam K, Sundquist SM, Lucero AS, Lujan BJ, Tao W, Porco TC, Roorda A, Duncan JL. Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment. Invest Ophthalmol Vis Sci. 2011;52:2219–26.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  57. Zhang K, Hopkins JJ, Heier JS, Birch DG, Halperin LS, Albini TA, Brown DM, Jaffe GJ, Tao W, Williams GA. Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc Natl Acad Sci U S A. 2011;108:6241–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  58. Andrieu-Soler C, Aubert-Pouessel A, Doat M, Picaud S, Halhal M, Simonutti M, Venier-Julienne MC, Benoit JP, Behar-Cohen F. Intravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rd1/rd1 mouse. Mol Vis. 2005;11:1002–11.

    CAS  PubMed  Google Scholar 

  59. Buch PK, MacLaren RE, Duran Y, Balaggan KS, MacNeil A, Schlichtenbrede FC, Smith AJ, Ali RR. In contrast to AAV-mediated CNTF expression, AAV-mediated GDNF expression enhances gene replacement therapy in rodent models of retinal degeneration. Mol Ther. 2006;14:700–9.

    Article  CAS  PubMed  Google Scholar 

  60. Leveillard T, Mohand-Said S, Lorentz O, Hicks D, Fintz AC, Clerin E, Simonutti M, Forster V, Cavusoglu N, Chalmel F, Dolle P, Poch O, Lambrou G, Sahel JA. Identification and characterization of rod-derived cone viability factor. Nat Genet. 2004;36:755–9.

    Article  CAS  PubMed  Google Scholar 

  61. Fridlich R, Delalande F, Jaillard C, Lu J, Poidevin L, Cronin T, Perrocheau L, Millet-Puel G, Niepon ML, Poch O, Holmgren A, Van Dorsselaer A, Sahel JA, Leveillard T. The thioredoxin-like protein rod-derived cone viability factor (RdCVFL) interacts with TAU and inhibits its phosphorylation in the retina. Mol Cell Proteomics. 2009;8:1206–18.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  62. Leveillard T, Sahel JA. Rod-derived cone viability factor for treating blinding diseases: from clinic to redox signaling. Sci Transl Med. 2010;2:26ps16.

    Article  PubMed Central  PubMed  Google Scholar 

  63. Tehovnik EJ, Slocum WM, Smirnakis SM, Tolias AS. Microstimulation of visual cortex to restore vision. Prog Brain Res. 2009;175:347–75.

    Article  PubMed  Google Scholar 

  64. Schiller PH, Slocum WM, Kwak MC, Kendall GL, Tehovnik EJ. New methods devised specify the size and color of the spots monkeys see when striate cortex (area V1) is electrically stimulated. Proc Natl Acad Sci U S A. 2011;108:17809–14.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  65. Normann RA, Greger B, House P, Romero SF, Pelayo F, Fernandez E. Toward the development of a cortically based visual neuroprosthesis. J Neural Eng. 2009;6:035001.

    Article  PubMed Central  PubMed  Google Scholar 

  66. Veraart C, Duret F, Brelen M, Delbeke J. Vision rehabilitation with the optic nerve visual prosthesis. Conf Proc IEEE Eng Med Biol Soc. 2004;6:4163–4.

    CAS  PubMed  Google Scholar 

  67. Veraart C, Wanet-Defalque MC, Gerard B, Vanlierde A, Delbeke J. Pattern recognition with the optic nerve visual prosthesis. Artif Organs. 2003;27:996–1004.

    Article  PubMed  Google Scholar 

  68. Brelen ME, Duret F, Gerard B, Delbeke J, Veraart C. Creating a meaningful visual perception in blind volunteers by optic nerve stimulation. J Neural Eng. 2005;2:S22–8.

    Article  CAS  PubMed  Google Scholar 

  69. Humayun MS, de Juan Jr E, Dagnelie G, Greenberg RJ, Propst RH, Phillips DH. Visual perception elicited by electrical stimulation of retina in blind humans. Arch Ophthalmol. 1996;114:40–6.

    Article  CAS  PubMed  Google Scholar 

  70. Shannon RV. A model of safe levels for electrical stimulation. IEEE Trans Biomed Eng. 1992;39:424–6.

    Article  CAS  PubMed  Google Scholar 

  71. Humayun MS, Weiland JD, Fujii GY, Greenberg R, Williamson R, Little J, Mech B, Cimmarusti V, Van Boemel G, Dagnelie G, de Juan E. Visual perception in a blind subject with a chronic microelectronic retinal prosthesis. Vision Res. 2003;43:2573–81.

    Article  PubMed  Google Scholar 

  72. Zrenner E. Will retinal implants restore vision? Science. 2002;295:1022–5.

    Article  CAS  PubMed  Google Scholar 

  73. Humayun MS, Dorn JD, Ahuja AK, Caspi A, Filley E, Dagnelie G, Salzmann J, Santos A, Duncan J, daCruz L, Mohand-Said S, Eliott D, McMahon MJ, Greenberg RJ. Preliminary 6 month results from the Argus II epiretinal prosthesis feasibility study. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:4566–8.

    PubMed Central  PubMed  Google Scholar 

  74. Humayun MS, Dorn JD, da Cruz L, Dagnelie G, Sahel JA, Stanga PE, Cideciyan AV, Duncan JL, Eliott D, Filley E, Ho AC, Santos A, Safran AB, Arditi A, Del Priore LV, Greenberg RJ. Interim results from the international trial of Second Sight’s visual prosthesis. Ophthalmology. 2012;119:779–88.

    Article  PubMed Central  PubMed  Google Scholar 

  75. Ahuja AK, Dorn JD, Caspi A, McMahon MJ, Dagnelie G, Dacruz L, Stanga P, Humayun MS, Greenberg RJ. Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task. Br J Ophthalmol. 2011;95:539–43.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  76. Dorn JD, Ahuja AK, Caspi A, da Cruz L, Dagnelie G, Sahel JA, Greenberg RJ, McMahon MJ. The detection of motion by blind subjects with the epiretinal 60-electrode (Argus II) retinal prosthesis. JAMA Ophthalmol. 2013;131(2):183–9.

    Google Scholar 

  77. Da Cruz L, Coley BF, Dorn J, Merlini F, Filley E, Christopher P, Chen FK, Wuyyuru V, Sahel J, Stanga P, Humayun M, Greenberg RJ, Dagnelie G. The Argus II epiretinal prosthesis system allows letter and word reading and long-term function in patients with profound vision loss. Br J Ophthalmol. 2013;97(5):632–6.

    Google Scholar 

  78. Lauritzen TZ, Harris J, Mohand-Said S, Sahel JA, Dorn JD, McClure K, Greenberg RJ. Reading visual braille with a retinal prosthesis. Front Neurosci. 2012;6:168.

    Article  PubMed Central  PubMed  Google Scholar 

  79. Chader GJ, Weiland J, Humayun MS. Artificial vision: needs, functioning, and testing of a retinal electronic prosthesis. Prog Brain Res. 2009;175:317–32.

    Article  PubMed  Google Scholar 

  80. Kelly SK, Shire DB, Chen J, Doyle P, Gingerich MD, Cogan SF, Drohan WA, Behan S, Theogarajan L, Wyatt JL, Rizzo 3rd JF. A hermetic wireless subretinal neurostimulator for vision prostheses. IEEE Trans Biomed Eng. 2011;58:3197–205.

    Article  PubMed  Google Scholar 

  81. Rizzo 3rd JF. Update on retinal prosthetic research: the Boston Retinal Implant Project. J Neuroophthalmol. 2011;31:160–8.

    Article  PubMed  Google Scholar 

  82. Chow AY, Chow VY, Packo KH, Pollack JS, Peyman GA, Schuchard R. The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa. Arch Ophthalmol. 2004;122:460–9.

    Article  PubMed  Google Scholar 

  83. Zrenner E. The subretinal implant: can microphotodiode arrays replace degenerated retinal photoreceptors to restore vision? Ophthalmologica. 2002;216 Suppl 1:8–20; discussion 52–3.

    Article  PubMed  Google Scholar 

  84. Zrenner E, Bartz-Schmidt KU, Benav H, Besch D, Bruckmann A, Gabel VP, Gekeler F, Greppmaier U, Harscher A, Kibbel S, Koch J, Kusnyerik A, Peters T, Stingl K, Sachs H, Stett A, Szurman P, Wilhelm B, Wilke R. Subretinal electronic chips allow blind patients to read letters and combine them to words. Proc Biol Sci. 2011;278:1489–97.

    Article  PubMed Central  PubMed  Google Scholar 

  85. Stingl K, Bartz-Schmidt KU, Besch D, Braun A, Bruckmann A, Gekeler F, Greppmaier U, Hipp S, Hortdorfer G, Kernstock C, Koitschev A, Kusnyerik A, Sachs H, Schatz A, Stingl KT, Peters T, Wilhelm B, Zrenner E. Artificial vision with wirelessly powered subretinal electronic implant alpha-IMS. Proc Biol Sci. 2013;280:20130077.

    Article  PubMed Central  PubMed  Google Scholar 

  86. Gerding H. A new approach towards a minimal invasive retina implant. J Neural Eng. 2007;4:S30–7.

    Article  CAS  PubMed  Google Scholar 

  87. Mathieson K, Loudin J, Goetz G, Huie P, Wang L, Kamins TI, Galambos L, Smith R, Harris JS, Sher A, Palanker D. Photovoltaic retinal prosthesis with high pixel density. Nat Photonics. 2012;6:391–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  88. Palanker D, Vankov A, Huie P, Baccus S. Design of a high-resolution optoelectronic retinal prosthesis. J Neural Eng. 2005;2:S105–20.

    Article  PubMed  Google Scholar 

  89. Djilas M, Oles C, Lorach H, Bendali A, Degardin J, Dubus E, Lissorgues-Bazin G, Rousseau L, Benosman R, Ieng SH, Joucla S, Yvert B, Bergonzo P, Sahel J, Picaud S. Three-dimensional electrode arrays for retinal prostheses: modeling, geometry optimization and experimental validation. J Neural Eng. 2011;8:046020.

    Article  CAS  PubMed  Google Scholar 

  90. Lorach H, Benosman R, Marre O, Ieng SH, Sahel JA, Picaud S. Artificial retina: the multichannel processing of the mammalian retina achieved with a neuromorphic asynchronous light acquisition device. J Neural Eng. 2012;9:066004.

    Article  PubMed  Google Scholar 

  91. Auvray M, Hanneton S, O’Regan JK. Learning to perceive with a visuo-auditory substitution system: localisation and object recognition with ‘the vOICe”. Perception. 2007;36:416–30.

    Article  PubMed  Google Scholar 

  92. Merabet LB, Battelli L, Obretenova S, Maguire S, Meijer P, Pascual-Leone A. Functional recruitment of visual cortex for sound encoded object identification in the blind. Neuroreport. 2009;20:132–8.

    Article  PubMed Central  PubMed  Google Scholar 

  93. Renier L, De Volder AG. Vision substitution and depth perception: early blind subjects experience visual perspective through their ears. Disabil Rehabil Assist Technol. 2010;5:175–83.

    Article  PubMed  Google Scholar 

  94. Striem-Amit E, Cohen L, Dehaene S, Amedi A. Reading with sounds: sensory substitution selectively activates the visual word form area in the blind. Neuron. 2012;76:640–52.

    Article  CAS  PubMed  Google Scholar 

  95. Amedi A, Stern WM, Camprodon JA, Bermpohl F, Merabet L, Rotman S, Hemond C, Meijer P, Pascual-Leone A. Shape conveyed by visual-to-auditory sensory substitution activates the lateral occipital complex. Nat Neurosci. 2007;10:687–9.

    Article  CAS  PubMed  Google Scholar 

  96. Striem-Amit E, Dakwar O, Reich L, Amedi A. The large-scale organization of “visual” streams emerges without visual experience. Cereb Cortex. 2011;22:1698–709.

    Article  PubMed  Google Scholar 

  97. Sampaio E, Maris S, Bach-y-Rita P. Brain plasticity: ‘visual’ acuity of blind persons via the tongue. Brain Res. 2001;908:204–7.

    Article  CAS  PubMed  Google Scholar 

  98. Ptito M, Moesgaard SM, Gjedde A, Kupers R. Cross-modal plasticity revealed by electrotactile stimulation of the tongue in the congenitally blind. Brain. 2005;128:606–14.

    Article  PubMed  Google Scholar 

  99. Chebat DR, Rainville C, Kupers R, Ptito M. Tactile-‘visual’ acuity of the tongue in early blind individuals. Neuroreport. 2007;18:1901–4.

    Article  PubMed  Google Scholar 

  100. Bi A, Cui J, Ma YP, Olshevskaya E, Pu M, Dizhoor AM, Pan ZH. Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration. Neuron. 2006;50:23–33.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  101. Busskamp V, Duebel J, Balya D, Fradot M, Viney TJ, Siegert S, Groner AC, Cabuy E, Forster V, Seeliger M, Biel M, Humphries P, Paques M, Mohand-Said S, Trono D, Deisseroth K, Sahel JA, Picaud S, Roska B. Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa. Science. 2010;329:413–7.

    Article  CAS  PubMed  Google Scholar 

  102. Nagel G, Szellas T, Huhn W, Kateriya S, Adeishvili N, Berthold P, Ollig D, Hegemann P, Bamberg E. Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc Natl Acad Sci U S A. 2003;100:13940–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  103. Schobert B, Lanyi JK. Halorhodopsin is a light-driven chloride pump. J Biol Chem. 1982;257:10306–13.

    CAS  PubMed  Google Scholar 

  104. Ishizuka T, Kakuda M, Araki R, Yawo H. Kinetic evaluation of photosensitivity in genetically engineered neurons expressing green algae light-gated channels. Neurosci Res. 2006;54:85–94.

    Article  CAS  PubMed  Google Scholar 

  105. Tomita H, Sugano E, Yawo H, Ishizuka T, Isago H, Narikawa S, Kugler S, Tamai M. Restoration of visual response in aged dystrophic RCS rats using AAV-mediated channelopsin-2 gene transfer. Invest Ophthalmol Vis Sci. 2007;48:3821–6.

    Article  PubMed  Google Scholar 

  106. Sahel JA, Roska B. Gene therapy for blindness. Annu Rev Neurosci. 2013;36:467–88.

    Google Scholar 

  107. Busskamp V, Picaud S, Sahel JA, Roska B. Optogenetic therapy for retinitis pigmentosa. Gene Ther. 2011;19:169–75.

    Article  PubMed  CAS  Google Scholar 

  108. Seiler MJ, Aramant RB, Thomas BB, Peng Q, Sadda SR, Keirstead HS. Visual restoration and transplant connectivity in degenerate rats implanted with retinal progenitor sheets. Eur J Neurosci. 2010;31:508–20.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  109. Seiler MJ, Thomas BB, Chen Z, Wu R, Sadda SR, Aramant RB. Retinal transplants restore visual responses: trans-synaptic tracing from visually responsive sites labels transplant neurons. Eur J Neurosci. 2008;28:208–20.

    Article  PubMed  Google Scholar 

  110. Yang Y, Mohand-Said S, Leveillard T, Fontaine V, Simonutti M, Sahel JA. Transplantation of photoreceptor and total neural retina preserves cone function in P23H rhodopsin transgenic rat. PLoS One. 2010;5:e13469.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  111. Radtke ND, Aramant RB, Petry HM, Green PT, Pidwell DJ, Seiler MJ. Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium. Am J Ophthalmol. 2008;146:172–82.

    Article  PubMed  Google Scholar 

  112. Marchetti V, Krohne TU, Friedlander DF, Friedlander M. Stemming vision loss with stem cells. J Clin Invest. 2010;120:3012–21.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  113. Singh MS, MacLaren RE. Stem cells as a therapeutic tool for the blind: biology and future prospects. Proc Biol Sci. 2011;278:3009–16.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  114. Baker PS, Brown GC. Stem-cell therapy in retinal disease. Curr Opin Ophthalmol. 2009;20:175–81.

    Article  PubMed  Google Scholar 

  115. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292:154–6.

    Article  CAS  PubMed  Google Scholar 

  116. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76.

    Article  CAS  PubMed  Google Scholar 

  117. Jin ZB, Takahashi M. Generation of retinal cells from pluripotent stem cells. Prog Brain Res. 2012;201:171–81.

    Article  PubMed  Google Scholar 

  118. Lamba DA, Karl MO, Ware CB, Reh TA. Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc Natl Acad Sci U S A. 2006;103:12769–74.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  119. Vugler A, Carr AJ, Lawrence J, Chen LL, Burrell K, Wright A, Lundh P, Semo M, Ahmado A, Gias C, da Cruz L, Moore H, Andrews P, Walsh J, Coffey P. Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp Neurol. 2008;214:347–61.

    Article  CAS  PubMed  Google Scholar 

  120. Osakada F, Ikeda H, Mandai M, Wataya T, Watanabe K, Yoshimura N, Akaike A, Sasai Y, Takahashi M. Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotechnol. 2008;26:215–24.

    Article  CAS  PubMed  Google Scholar 

  121. Meyer JS, Shearer RL, Capowski EE, Wright LS, Wallace KA, McMillan EL, Zhang SC, Gamm DM. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2009;106:16698–703.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  122. Cramer AO, MacLaren RE. Translating induced pluripotent stem cells from bench to bedside: application to retinal diseases. Curr Gene Ther. 2013;13:139–51.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  123. Pearson RA, Barber AC, Rizzi M, Hippert C, Xue T, West EL, Duran Y, Smith AJ, Chuang JZ, Azam SA, Luhmann UF, Benucci A, Sung CH, Bainbridge JW, Carandini M, Yau KW, Sowden JC, Ali RR. Restoration of vision after transplantation of photoreceptors. Nature. 2012;485:99–103.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  124. Singh MS, Charbel Issa P, Butler R, Martin C, Lipinski DM, Sekaran S, Barnard AR, MacLaren RE. Reversal of end-stage retinal degeneration and restoration of visual function by photoreceptor transplantation. Proc Natl Acad Sci U S A. 2013;110:1101–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  125. Tsubota K, Satake Y, Kaido M, Shinozaki N, Shimmura S, Bissen-Miyajima H, Shimazaki J. Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med. 1999;340:1697–703.

    Article  CAS  PubMed  Google Scholar 

  126. Polosukhina A, Litt J, Tochitsky I, Nemargut J, Sychev Y, De Kouchkovsky I, Huang T, Borges K, Trauner D, Van Gelder RN, Kramer RH. Photochemical restoration of visual responses in blind mice. Neuron. 2012;75:271–82.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  127. Yang Y, Mohand-Said S, Danan A, Simonutti M, Fontaine V, Clerin E, Picaud S, Léveillard T, Sahel JA. Functional cone rescue by RdCVF protein in a dominant model of retinitis pigmentosa. Mol Ther. 2009;17:785–795.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut de la Vision, Sorbonne Universités, UPMC Univ Paris 06, UMR_S 968, INSERM, U_968, CNRS, UMR_7210, Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts, INSERM-DHOS CIC 1423, Paris, 75012, France

    José-Alain Sahel

  2. Fondation Ophtalmologique Adolphe de Rothschild, Paris, 75019, France

    José-Alain Sahel

  3. Institut de la Vision, Sorbonne Universités, UPMC Univ Paris 06, UMR_S 968, Inserm, U_968; CNRS, UMR_7210, Paris, France

    Katia Marazova

Authors
  1. José-Alain Sahel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katia Marazova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to José-Alain Sahel .

Editor information

Editors and Affiliations

  1. Service d’Exploration de la Vision et Neuro-ophtalmologie, Centre Hospitalier Universitaire de Lille, Hôpital Roger Salengro, Lille Cedex, France

    Bernard Puech

  2. Department of Ophthalmology, Ghent University Hospital, Ghent University, Ghent, Belgium

    Jean-Jacques De Laey

  3. Department of Electrophysiology, Moorfields Eye Hospital, London, United Kingdom

    Graham E. Holder

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sahel, JA., Marazova, K. (2014). Future Therapies for Retinitis Pigmentosa. In: Puech, B., De Laey, JJ., Holder, G. (eds) Inherited Chorioretinal Dystrophies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69466-3_53

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69466-3_53

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69464-9

  • Online ISBN: 978-3-540-69466-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation